Kenneth S. Wilson

5.3k total citations · 3 hit papers
50 papers, 3.9k citations indexed

About

Kenneth S. Wilson is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Kenneth S. Wilson has authored 50 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 13 papers in Surgery. Recurrent topics in Kenneth S. Wilson's work include Lymphoma Diagnosis and Treatment (7 papers), Heavy Metal Exposure and Toxicity (6 papers) and Nausea and vomiting management (5 papers). Kenneth S. Wilson is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Heavy Metal Exposure and Toxicity (6 papers) and Nausea and vomiting management (5 papers). Kenneth S. Wilson collaborates with scholars based in Canada, United States and Singapore. Kenneth S. Wilson's co-authors include Ivo A. Olivotto, Joseph Ragaz, Stewart M. Jackson, C Coppin, John J. Spinelli, Nhu Le, Ian H. Plenderleith, Margaret A. Knowling, Séamus O’Reilly and Richard Klasa and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Kenneth S. Wilson

49 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer

1997 1.3k citations Joseph Ragaz, John J. Spinelli et al. New England Journal of Medicine profile →
Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial

2005 757 citations Joseph Ragaz, Ivo A. Olivotto et al. JNCI Journal of the National Cancer Institute profile →
Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

2005 744 citations Laurie H. Sehn, Jane Donaldson et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth S. Wilson Canada	20	1.8k	1.7k	1.6k	1.2k	527	50	3.9k
Yazid Belkacémi France	34	1.4k 0.8×	1.1k 0.6×	1.3k 0.9×	960 0.8×	870 1.7×	212	4.1k
Harald Anderson Sweden	34	770 0.4×	970 0.6×	1.3k 0.8×	639 0.5×	956 1.8×	79	4.1k
Diana Fischer United States	28	1.1k 0.6×	998 0.6×	1.1k 0.7×	613 0.5×	569 1.1×	65	3.0k
Arne Wallgren Sweden	35	1.6k 0.9×	964 0.6×	1.8k 1.1×	757 0.6×	619 1.2×	93	3.8k
James J. Dignam United States	24	1.2k 0.7×	651 0.4×	1.8k 1.1×	353 0.3×	1.0k 2.0×	55	3.5k
Mars B. vanʼt Veer Netherlands	24	507 0.3×	1.7k 1.0×	1.0k 0.7×	207 0.2×	806 1.5×	59	3.8k
R Zucali Italy	40	5.1k 2.8×	3.9k 2.3×	3.7k 2.4×	2.6k 2.1×	1.4k 2.7×	97	8.4k
Barry C. Lembersky United States	31	1.1k 0.6×	555 0.3×	2.5k 1.6×	663 0.5×	764 1.4×	82	3.3k
Roy E. Smith United States	20	677 0.4×	791 0.5×	1.1k 0.7×	518 0.4×	387 0.7×	52	2.5k
Marie‐Cécile Le Deley France	37	501 0.3×	1.4k 0.8×	1.3k 0.8×	682 0.6×	1.9k 3.7×	177	5.0k

Countries citing papers authored by Kenneth S. Wilson

Since Specialization

Citations

This map shows the geographic impact of Kenneth S. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth S. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth S. Wilson more than expected).

Fields of papers citing papers by Kenneth S. Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth S. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth S. Wilson. The network helps show where Kenneth S. Wilson may publish in the future.

Co-authorship network of co-authors of Kenneth S. Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth S. Wilson. A scholar is included among the top collaborators of Kenneth S. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth S. Wilson. Kenneth S. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schallenberg, Marc, David P. Hamilton, H.A. Robertson, et al.. (2017). Multiple lines of evidence determine robust nutrient load limits required to safeguard a threatened lake/lagoon system. New Zealand Journal of Marine and Freshwater Research. 51(1). 78–95. 19 indexed citations

Ragaz, Joseph, et al.. (2010). Abstract P6-09-09: Dual Estrogen Effects on Breast Cancer: Endogenous Estrogen Stimulates, Exogenous Estrogen Protects. Further Investigation of Estrogen Chemoprevention Is Warranted. Cancer Research. 70(24_Supplement). P6–9. 4 indexed citations

Wilson, Kenneth S., et al.. (2009). The BC Cancer Agency Compassionate Access Program: Outcome Analysis of Patients with Esophagogastric Cancer. Current Oncology. 16(5). 9–14. 1 indexed citations

Wilson, Kenneth S., et al.. (2009). Raltitrexed: optimism and reality. Expert Opinion on Drug Metabolism & Toxicology. 5(11). 1447–1454. 17 indexed citations

Wilson, Kenneth S., et al.. (2007). Adjuvant Therapy with Raltitrexed in Patients with Colorectal Cancer Intolerant of 5-Fluorouracil: British Columbia Cancer Agency Experience. Cancer Investigation. 25(8). 711–714. 14 indexed citations

Wilson, Kenneth S., Laurie H. Sehn, Brian Berry, et al.. (2007). CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma. Leukemia & lymphoma. 48(6). 1102–1109. 46 indexed citations

Shustik, Chaim, Andrew R. Belch, Sue Robinson, et al.. (2006). A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7. British Journal of Haematology. 136(2). 203–211. 58 indexed citations

Wilson, Kenneth S.. (2006). Clinical Activity of Celecoxib in Metastatic Malignant Melanoma. Cancer Investigation. 24(8). 740–746. 10 indexed citations

Sehn, Laurie H., Jane Donaldson, Mukesh Chhanabhai, et al.. (2005). Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia. Journal of Clinical Oncology. 23(22). 5027–5033. 744 indexed citations breakdown →

10.

Wilson, Kenneth S. & Sharon J. Allan. (2005). Clinical activity of celecoxib (CXB) in metastatic malignant melanoma (MMM). Journal of Clinical Oncology. 23(16_suppl). 7555–7555. 2 indexed citations

11.

Ragaz, Joseph, Ivo A. Olivotto, Kenneth S. Wilson, John J. Spinelli, & Ralph E. Durand. (2005). RESPONSE: Re: Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial. JNCI Journal of the National Cancer Institute. 97(15). 1163–1164. 5 indexed citations

12.

Wilson, Kenneth S., Janet I. Sprent, & D. W. Hopkins. (1997). Nitrification in Antarctic soils. Nature. 385(6615). 404–404. 15 indexed citations

13.

Lofters, W., Joseph L. Pater, Benny Zee, et al.. (1997). Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.. Journal of Clinical Oncology. 15(8). 2966–2973. 84 indexed citations

14.

Warr, David, Peter Venner, Joseph L. Pater, et al.. (1993). A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. European Journal of Cancer. 29(1). 33–36. 29 indexed citations

15.

Levitt, Martin, David Warr, Louise Yelle, et al.. (1993). Ondansetron Compared with Dexamethasone and Metoclopramide as Antiemetics in the Chemotherapy of Breast Cancer with Cyclophosphamide, Methotrexate, and Fluorouracil. New England Journal of Medicine. 328(15). 1081–1084. 52 indexed citations

16.

Eisenhauer, Elizabeth A., William K. Evans, Nevin Murray, et al.. (1988). A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. Investigational New Drugs. 6(4). 327–329. 22 indexed citations

17.

Wilson, Kenneth S., W Shelley, Andrew R. Belch, et al.. (1987). Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.. PubMed. 71(10). 981–2. 8 indexed citations

18.

Wilson, Kenneth S., et al.. (1984). Statistical approach to evaluate the relation of coal mining, land reclamation, and surface-water quality in Ohio. [779 sites; 1975 to 1982]. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations

19.

Wilson, Kenneth S., et al.. (1982). Fatal pneumothorax in “BCNU lung”. Medical and Pediatric Oncology. 10(2). 195–199. 8 indexed citations

20.

Wilson, Kenneth S., et al.. (1982). Low‐dose bleomycin lung. Medical and Pediatric Oncology. 10(3). 283–288. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact